Chengyuan Tang
- Nephrology top 0.2%
- Acute Kidney Injury Research 24
- Renal Diseases and Glomerulopathies 12
- Chronic Kidney Disease and Diabetes 11
- Dialysis and Renal Disease Management 10
- Clinical Biochemistry top 0.5%
-
- Chemotherapy-induced organ toxicity mitigation 14
- Biomedical Research and Pathophysiology 8
- Epidemiology top 2%
- Autophagy in Disease and Therapy 22
- Cancer Research top 5%
-
- Endoplasmic Reticulum Stress and Disease 8
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Chengyuan Tang
98 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Nephrology 1.8k
- Clinical Biochemistry 528
- Pathology and Forensic Medicine 925
- Epidemiology 1.5k
- Cancer Research 643
Countries citing papers authored by Chengyuan Tang
This map shows the geographic impact of Chengyuan Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyuan Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyuan Tang more than expected).
Fields of papers citing papers by Chengyuan Tang
This network shows the impact of papers produced by Chengyuan Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyuan Tang. The network helps show where Chengyuan Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengyuan Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 43 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 21 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 30 | |
| 13 | 2020 | 131 | |
| 14 | 2020 | 8 | |
| 15 | 2019 | 192 | |
| 16 | 2019 | 27 | |
| 17 | 2018 | 90 | |
| 18 | 2016 | 69 | |
| 19 | 2014 | 85 | |
| 20 | 2013 | 11 |
About Chengyuan Tang
Chengyuan Tang is a scholar working on Nephrology, Pathology and Forensic Medicine and Geriatrics and Gerontology, having authored 100 papers that have together received 6.1k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (24 papers), Autophagy in Disease and Therapy (22 papers), Chemotherapy-induced organ toxicity mitigation (14 papers), Renal Diseases and Glomerulopathies (12 papers), Chronic Kidney Disease and Diabetes (11 papers), Dialysis and Renal Disease Management (10 papers), Biomedical Research and Pathophysiology (8 papers) and Endoplasmic Reticulum Stress and Disease (8 papers). The work is most often cited by research in Nephrology (1.8k citations), Clinical Biochemistry (528 citations) and Pathology and Forensic Medicine (925 citations). Chengyuan Tang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zheng Dong, Zhiwen Liu, Man J. Livingston, Juan Cai, Liyu He, Shaoqun Shu, Fuyou Liu, Guochun Chen, Xiao-Ming Yin and Lin Sun. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.